相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Disentangling Pro-mitotic Signaling during Cell Cycle Progression using Time-Resolved Single-Cell Imaging
Manuela Benary et al.
CELL REPORTS (2020)
Acute lymphoblastic leukaemia
Florent Malard et al.
LANCET (2020)
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
Rui-Xue Huang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
DNA double-strand break repair pathway choice-from basic biology to clinical exploitation
Ron D. Jachimowicz et al.
CELL CYCLE (2019)
Multicomponent assemblies in DNA-double-strand break repair by NHEJ
Ales Hnizda et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2019)
Blocking ATM-dependent NF-κB pathway overcomes niche protection and improves chemotherapy response in acute lymphoblastic leukemia
Ya-Li Chen et al.
LEUKEMIA (2019)
Mutagenic players in ALL progression and their associated signaling pathways
Saadiya Zia et al.
CANCER GENETICS (2019)
Inhibition of Wee1 sensitizes AML cells to ATR inhibitor VE-822-induced DNA damage and apoptosis
Wenxiu Qi et al.
BIOCHEMICAL PHARMACOLOGY (2019)
DNA double-strand break repair-pathway choice in somatic mammalian cells
Ralph Scully et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia
Andrea Ghelli Luserna Di Rora et al.
CANCERS (2019)
Radio-sensitizing effects of VE-821 and beyond: Distinct phosphoproteomic and metabolomic changes after ATR inhibition in irradiated MOLT-4 cells
Barbora Salovska et al.
PLOS ONE (2018)
Metronomic oral doxorubicin in combination of Chkl inhibitor MK-8776 for p53-deficient breast cancer treatment
Seung Woo Chung et al.
BIOMATERIALS (2018)
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
Andrea Ghelli Luserna Di Rora et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
DNA replication stress and cancer chemotherapy
Hiroyuki Kitao et al.
CANCER SCIENCE (2018)
DNA replication stress: from molecular mechanisms to human disease
Sergio Munoz et al.
CHROMOSOMA (2017)
The DNA damage response pathway in normal hematopoiesis and malignancies
Domenico Delia et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
The cell cycle checkpoint inhibitors in the treatment of leukemias
A. Ghelli Luserna di Rora et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
CC-115, a dual inhibitor of mTOR kinase and DNA-PK, blocks DNA damage repair pathways and selectively inhibits ATM-deficient cell growth in vitro
Toshiya Tsuji et al.
ONCOTARGET (2017)
Combination therapeutics of Nilotinib and radiation in acute lymphoblastic leukemia as an effective method against drug-resistance
Kamran Kaveh et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Spatiotemporal regulation of posttranslational modifications in the DNA damage response
Nico P. Dantuma et al.
EMBO JOURNAL (2016)
Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia
Rachel Thijssen et al.
BLOOD (2016)
Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia
Andrea Ghelli Luserna Di Rora et al.
ONCOTARGET (2016)
Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cells
Jana Zemanova et al.
ONCOTARGET (2016)
Topotecan synergizes with CHEK1 (CHK1) inhibitor to induce apoptosis in ovarian cancer cells
Marianne K. Kim et al.
BMC CANCER (2015)
New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia
Elias Jabbour et al.
CANCER (2015)
Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors
Adil I. Daud et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia
Ilaria Iacobucci et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms
Constance King et al.
MOLECULAR CANCER THERAPEUTICS (2015)
AZD1775 sensitizes T cell acute lymphoblastic leukemia cells to cytarabine by promoting apoptosis over DNA repair
James B. Ford et al.
ONCOTARGET (2015)
Targeting ATM-deficient CLL through interference with DNA repair pathways
Gero Knittel et al.
FRONTIERS IN GENETICS (2015)
CHK1 overexpression in T-cell acute lymphoblastic leukemia is essential for proliferation and survival by preventing excessive replication stress
L. M. Sarmento et al.
ONCOGENE (2015)
The checkpoint 1 kinase inhibitor LY2603618 induces cell cycle arrest, DNA damage response and autophagy in cancer cells
Feng-Ze Wang et al.
APOPTOSIS (2014)
FOXM1: An emerging master regulator of DNA damage response and genotoxic agent resistance
Stefania Zona et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2014)
Radiosensitization of Human Leukemic HL-60 Cells by ATR Kinase Inhibitor (VE-821): Phosphoproteomic Analysis
Barbora Salovska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Radio-sensitization of human leukaemic MOLT-4 cells by DNA-dependent protein kinase inhibitor, NU7441
Ales Tichy et al.
RADIATION AND ENVIRONMENTAL BIOPHYSICS (2014)
Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches
Felix Dietlein et al.
TRENDS IN GENETICS (2014)
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer
Cynthia X. Ma et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis
Wynand P. Roos et al.
CANCER LETTERS (2013)
DNA-Damaging Agents in Cancer Chemotherapy: Serendipity and Chemical Biology
Kahlin Cheung-Ong et al.
CHEMISTRY & BIOLOGY (2013)
Identification of Preferred Chemotherapeutics for Combining with a CHK1 Inhibitor
Yang Xiao et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Acute lymphoblastic leukaemia
Hiroto Inaba et al.
LANCET (2013)
CHK1 levels correlate with sensitization to pemetrexed by CHK1 inhibitors in non-small cell lung cancer cells
Svetlana Grabauskiene et al.
LUNG CANCER (2013)
Effects of Selective Checkpoint Kinase 1 Inhibition on Cytarabine Cytotoxicity in Acute Myelogenous Leukemia Cells In Vitro
Erin L. Schenk et al.
CLINICAL CANCER RESEARCH (2012)
Phase I and Pharmacologic Trial of Cytosine Arabinoside with the Selective Checkpoint 1 Inhibitor Sch 900776 in Refractory Acute Leukemias
Judith E. Karp et al.
CLINICAL CANCER RESEARCH (2012)
Playing the End Game: DNA Double-Strand Break Repair Pathway Choice
J. Ross Chapman et al.
MOLECULAR CELL (2012)
Familial pancreatic cancer-current knowledge
Detlef K. Bartsch et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
In Vitro and in Vivo Single-Agent Efficacy of Checkpoint Kinase 1 (Chk1) and 2 (Chk2) Inhibitor PF-0477736 (Pfizer) in B- and T-Acute Lymphoblastic Leukemia (ALL)
Ilaria Iacobucci et al.
BLOOD (2012)
NK314 potentiates antitumor activity with adult T-cell leukemia-lymphoma cells by inhibition of dual targets on topoisomerase IIα and DNA-dependent protein kinase
Takashi Hisatomi et al.
BLOOD (2011)
Discovery of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase as Potential Anticancer Agents
Jean-Damien Charrier et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Regulation of Homologous Recombination in Eukaryotes
Wolf-Dietrich Heyer et al.
ANNUAL REVIEW OF GENETICS, VOL 44 (2010)
Frequency and clinical relevance of DNA microsatellite alterations of the CDKN2A/B, ATM and p53 gene loci: a comparison between pediatric precursor T-cell lymphoblastic lymphoma and T-cell lymphoblastic leukemia
David Krieger et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
Alfons Meindl et al.
NATURE GENETICS (2010)
Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response
Hiroshi Nishida et al.
NUCLEIC ACIDS RESEARCH (2009)
Regulation of DNA repair throughout the cell cycle
Dana Branzei et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: A study of the Princess Margaret Hospital Phase II consortium
Stephen Welch et al.
GYNECOLOGIC ONCOLOGY (2007)
Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM
I Hickson et al.
CANCER RESEARCH (2004)
分享论文
